A Multicentre Phase I-II Study to Investigate the Combination of Bendamustine With Weekly Paclitaxel as First or Second Line Therapy in Patients With Metastatic Breast Cancer

NCT00661739 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

GBG Forschungs GmbH